Cannabis and Testosterone: Why One Reading Is Not the Answer
Cannabis and testosterone studies disagree. Separate a hormone reading, diagnosed deficiency and semen findings before making a health decision.
Professor High
Written by Professor High, our AI guide. See how we research and correct articles.
Cannabis and testosterone studies do not establish a consistent drop or a hormone-boosting benefit. Human studies find different links. A blood result, a diagnosis and a semen finding answer different questions. None turns cannabis into hormone treatment.
Higher testosterone and lower sperm counts appeared together in a Danish study. Gundersen et al., 2015.
Does cannabis lower testosterone in human studies?
There is no single result that describes everyone. These four studies show why the comparison matters. They observed people. They did not assign cannabis use at random.
A U.S. survey preserved a major null result
Researchers studied 1,577 men aged 18–59 in the 2011–2012 NHANES survey. After adjustment, testosterone did not differ between ever-users and never-users. More recent regular use was linked to higher levels. That timing result does not erase the group null. Thistle et al., 2017.
A Danish study measured hormones and semen
In 1,215 young men, use was linked to higher testosterone. Smoking more than once weekly was linked to 28% lower sperm concentration and 29% lower total count versus no use, after adjustment. Tobacco confounded the testosterone finding. Gundersen et al., 2015.
An infertility clinic found a different hormone association
Among 2,074 men seeking help for primary couple infertility, reported use was linked to lower testosterone and fewer normally shaped sperm. Cannabis did not independently predict the study’s hormone-status categories. Sperm concentration and movement also showed no adjusted link. Clinic patients differ from a community sample. Belladelli et al., 2022.
A 2026 study added blood-confirmed exposure
A Swiss study compared 47 users with 47 controls. All were aged 18–23. Blood markers confirmed the exposure groups. Users had higher testosterone. LH and FSH, two other reproductive hormones, did not differ significantly. Lifestyle factors remained possible explanations. This snapshot cannot establish a lasting benefit or a result for other ages. Galmiche et al., 2026.
These are selected examples, not a vote count. The slogan “weed raises T” discards the conflicting finding and the nulls. “Weed kills T” does the same.
Why do a hormone result, a diagnosis and fertility differ?
Keep the endpoint—the thing being measured—beside each headline.
| Question | Relevant evidence | What it cannot settle alone |
|---|---|---|
| Was testosterone different between groups? | A blood hormone comparison | Whether cannabis caused it |
| Does someone have testosterone deficiency? | Clinical review and confirmed low measurements | A diagnosis from one result |
| Were semen findings different? | Concentration, count, movement or shape | The chance that a particular couple will conceive |
The diagnosis row follows the Endocrine Society’s diagnostic guidance. The other rows describe the studies’ limits. A link between groups cannot forecast one person’s health.

A hormone finding does not establish a fertility benefit.
Our cannabis glossary helps decode product language. For another hormone example, the cannabis and cortisol lesson separates a feeling from a measured result.
What should you check before trusting a headline?
Read the comparison before the conclusion. Was “use” current, recent or ever in a lifetime? Were the participants young volunteers or patients already seeking fertility care? Was the result adjusted for tobacco and other differences? Did the study measure a hormone, semen, symptoms or pregnancies?
The studies used different exposure definitions and populations. Several relied on self-report. Even a blood-confirmed exposure group is not random assignment. These limits stop us from predicting one person’s result. A seller cannot turn a group finding into a hormone promise.
A paper about smoking marijuana cannot tell you how every oil, capsule or CBD product will affect you. Our capsules and pills guide explains why product contents and clinical claims belong in separate checks. The older-adult cannabis guide offers a useful way to organize a medicine and product review.
What can you bring to a clinical appointment?
For persistent symptoms or fertility concerns, bring the question to a clinician. The Endocrine Society requires symptoms plus confirmed, accurately measured low testosterone for this diagnosis. Its July 2026 statement calls for at least two early-morning, fasting tests. Symptoms alone cannot settle it. Follow the clinician’s testing instructions. Endocrine Society.
A short note can keep that visit focused. These are discussion prompts, not a scoring tool:
- What concern brought me here: symptoms, an existing result, or plans to conceive?
- What cannabis products do I use, by which route, and when did I last use them?
- What medicines and supplements should I disclose?
- What does this result answer, and what follow-up would answer my actual concern?
The Endocrine Society’s patient guide describes reviewing symptoms, medicines and history. It also warns that testosterone therapy can decrease sperm production and is not infertility treatment. Tell the clinician about fertility plans before considering treatment.
If changing cannabis use is difficult, our cannabis dependence and help-seeking lesson provides a separate place to start. A home hormone experiment should not replace care for either concern.
FAQ
Does a higher testosterone result mean cannabis improves fertility?
No. Hormone and semen outcomes differ, and an association does not prove benefit. A fertility concern needs its own clinical assessment.
Does one low testosterone test diagnose deficiency?
No. The Endocrine Society requires symptoms and consistently low, accurate measurements. A clinician should arrange and interpret repeat testing.
Will quitting cannabis raise my testosterone?
These comparisons do not establish a personal recovery timeline or a guaranteed increase. Discuss symptoms and changes in use with a clinician instead of treating a break as hormone therapy.
Can CBD or a lower-THC product protect my testosterone?
These studies do not establish that promise. A product with different THC or CBD content cannot inherit a hormone benefit from a group comparison.
Key takeaways
- Keep the hormone reading, clinical diagnosis and semen outcome separate.
- Conflicting associations and null results belong in the same account.
- Bring the actual concern, product history and medicines to a clinician.